Companies / 1AI

ALGORAE PHARMACEUTICALS LIMITED

ASX:1AIPharmaceuticals, Biotechnology & Life Sciences
2.03B shares on issueASX (delayed) · snapshot 28 Oct 20262.57B fully diluted+26.9% if every option and right converts$0.0095price · delayed$19.3MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 78.8% of what they think they own, once every option and right converts.

High
Dilution risk

Runway under 2 quarters; share count grew 20% in 24 months; 3 cash raises in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway1.2 quarters of funding
Share-count growth (24m)20.2%
Raise cadence (24m)3 cash raises
Options & rights overhang26.9% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

ALGORAE PHARMACEUTICALS LIMITED's ordinary share count grew 20.2% between May 2024 and July 2026, its latest share-count filing, to 2.03B shares. It raised capital three times in that period for total disclosed proceeds of A$4.3M, most recently a Placement in June 2026. Options and rights on issue could convert into 545M new shares, equal to 26.9% of the current share count, none of which are in the money; the nearest expiry falls in December 2029. The company has under 2 quarters of funding at the recent spend rate. No proposed securities issues (Appendix 3B) are currently pending.

AI-generated summary of this page's cited filings · updated 17 Oct 2026
Quick answers · 4

How much placement capacity does 1AI have left?

About 48% of the 15% placement capacity left, about 52% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.

How much cash does 1AI have?

In its quarterly cash report for the quarter ended 30 June 2026, Algorae Pharmaceuticals reported $3.9M of cash and estimated 4.3 quarters of funding available at its current rate of spending. That is the company's own estimate.

When do 1AI's options expire?

Unexercised options and rights equal 26.9% of Algorae Pharmaceuticals's shares on issue; the nearest expiry is Dec 2029.

How much has 1AI's share count grown?

Algorae Pharmaceuticals has 2.03B shares on issue as at 28 Oct 2026, up 20.2% over 24 months according to its Appendix 2A filings.

Get told when this changes
Get 1AI alerts
Free for up to 2 companies. A daily email when 1AI raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
26.9%
Options & rights overhang
0.0%
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply
3
Raises · last 12 months
1.2 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 2.03B per ASX (delayed) (snapshot 28 Oct 2026).
1.7B1.8B1.9B2.0BDec 24Nov 25Oct 26Cash raise · 16 June 2026Cash raise · 2 Apr 2026Cash raise · 17 Nov 20252.03B

Cash runway

1.2 qtrs OURS
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
Funds operations to about Feb 2027 at the reported spend rate.
$1.9M cash after burn.
FILED 4.3 qtrs · $3.9M cash · quarter ended 30 June 2026
OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.FILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.
Free account
12 cash reports on record — Cash runway history
Cash, net spend and cover trend from every Appendix 4C/5B and 4D/4E on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Unlock 1AI freeSee plans

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
2 Sept 20263H · cancellation1AI : ORDINARY FULLY PAID2.03BAppendix 3H
21 July 20263H · cancellation1AI : ORDINARY FULLY PAID2.03BAppendix 3H
6 July 20262A · quoted issue1AI : ORDINARY FULLY PAID2.03BAppendix 2A
19 June 20262A · quoted issue1AI : ORDINARY FULLY PAID2.03BAppendix 2A
19 June 20262A · quoted issue1AI : ORDINARY FULLY PAID2.02BAppendix 2A
Free account
37 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock 1AI freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock 1AI freeSee plans

Capital raises

3 cash raises in the last 24 months · 3 in the last 12 months

every 3.5 monthsaverage gap between raises
4.4 monthssince the most recent
17 Nov 2025 – 16 June 2026first to most recent in this window
—
Placement
16 June 2026 COMPLETE
Free account
5 issues (incl. 2 exercises or conversions) on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock 1AI freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
1 dated event on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock 1AI freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

About 48% of the 15% placement capacity left — about 52% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-10-28). Shares issued with holder approval are not added to the base, so the true headroom can be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock 1AI freeSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

26.9%
Options & rights overhang · of current shares
0.0%
In-the-money supply · at current price
545.4M
Potential new shares
Dec 2029
Nearest expiry
What this supply is, and what converts it
  • Price-triggered376.4M · 18.6% of shares
    Options and warrants — they convert when the share price clears their exercise price.
  • Condition-triggered169.0M · 8.3% of shares
    Performance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.

Exercise price on record: 376.4M priced, 169.0M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.

Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.

What a price move would switch on
272.7M545.4M$0.009 now0.25× today ($0.002) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.005) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.007) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.009) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.012) — 0 of the priced supply in the money, 0.0% of shares on issue1.5× today ($0.014) — 376.4M of the priced supply in the money, 18.6% of shares on issue2× today ($0.019) — 376.4M of the priced supply in the money, 18.6% of shares on issue3× today ($0.028) — 376.4M of the priced supply in the money, 18.6% of shares on issue5× today ($0.048) — 376.4M of the priced supply in the money, 18.6% of shares on issue10× today ($0.095) — 376.4M of the priced supply in the money, 18.6% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.009 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 1.5× today’s price, which takes it to 376.4M (18.6% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 169.0M (31.0% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
1AIATOptionsPrice-triggered$0.0141 Dec 2029376.4MFiling
1AIASPerformance rightsCondition-triggered——169.0MFiling Meeting

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.

A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.

Free account
2 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Unlock 1AI freeSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
28 Sept 2026David HainsworthOther off-market5.9M1.1M——3Y notice
5 Mar 2026DAVID HAINSWORTHOther313k——$4k3Y notice
22 Dec 2025BRADLEY LATHAMOther20.0M4.0M15.0M—3Y notice
Free account
9 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock 1AI freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.